Dwight Owen, MD, MS
Dr. Dwight Owen is a medical oncologist and researcher at the James Comprehensive Cancer Center in Columbus, Ohio. He specializes in treating patients with thoracic malignancies, including pleural mesothelioma, lung cancer, and thymic cancers. Dr. Owen says that what drove him into oncology was the human connection and the fact that it let him be his patients’ “home base.” He appreciates the ability to form long-term, special relationships with patients, even in the face of challenges.[1]
Education and Career
Dr. Owen attended medical school at the Trinity College Dublin School of Medicine and completed his internship and residency in Internal Medicine at SUNY Downstate Medical Center in Brooklyn, New York.
He then served as chief resident in Internal Medicine at Memorial Sloan-Kettering Cancer Center in New York and served as chief fellow in Hematology and Oncology at Ohio State University Wexner Medical Center. He also earned his Master of Science at The Ohio State University Graduate School.[1]
While still completing his fellowship at Ohio State, Dr. Owen expanded on the facility’s system-based education curriculum and led the development of a Quality Improvement Program to optimize procedure training.
Dr. Owen is currently a medical oncologist at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in Columbus. He specializes in treating lung cancer, mesothelioma, and thymic cancers.
In addition to caring for patients, Dr. Owen is an Assistant Professor of Internal Medicine in the Division of Medical Oncology and a member of the Translational Therapeutics Program.
He works on developing ways to better identify patients with thoracic cancers who will most benefit from the use of immunotherapy. He is also the thoracic malignancies Associate Editor for medical oncology at Mednet.[2]
Dr. Owen’s clinical focus is on using immunotherapy and other transformative treatments to overcome cancer’s ability to evade destruction by the immune system. He believes that his role is a combination of science, compassionate care, and education, and is excited about the promise of targeted treatments and other breakthroughs.
Research
Dr. Owen’s research focuses on understanding mechanisms of secondary resistance to targeted and immune-based therapies. He has been published in the Journal of Clinical Oncology, Journal of Thoracic Disease, and Journal of Oncology Practice.
He was the recipient of the Conquer Cancer Foundation’s Young Investigator Award bestowed by the American Society of Clinical Oncology.[1]
